Marykim Koch

MaryKim Koch is currently a Senior Executive Account Specialist in Rare Disease at AstraZeneca, where significant achievements include launching a new treatment and ranking among the top performers nationally in 2025. Prior to this role, MaryKim served as an Advisory Board Member focused on women's health at Responsum Health, where the project concluded due to funding challenges. Experience also includes working as a Clinical Rare Disease Liaison at Ultragenyx Pharmaceutical Inc., and as a Specialty Account Representative at AMAG Pharmaceuticals, earning accolades such as the 2018 President's Club winner. MaryKim's career began at Endo International plc as a Senior Medical Center Representative specializing in pediatric endocrinology. MaryKim holds a Bachelor of Science in Marketing and Management from Saint Mary's College Notre Dame.